Silvia Crestani
Mantova, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Role of rituximab in the treatment of postpartum acquired haemophilia A: a systematic review of the literature.
Journal: Blood transfusion = Trasfusione del sangue
Published: September 29, 2014
Recombinant activated factor VII in clinical practice: a 2014 update.
Journal: Journal of thrombosis and thrombolysis
Published: July 13, 2014
Hemostatic agents for bleeding: recombinant-activated factor VII and beyond.
Journal: Seminars in thrombosis and hemostasis
Published: June 18, 2014
ABO blood group and von Willebrand factor: biological implications.
Journal: Clinical chemistry and laboratory medicine
Published: May 27, 2014
Haemostatic abnormalities and thyroid disorders: the prospective observational MITH study
Journal: Recenti progressi in medicina
Published: March 15, 2014
ABO blood group and vascular disease: an update.
Journal: Seminars in thrombosis and hemostasis
Published: January 02, 2014
ABO blood group and risk of peripheral arterial thrombosis in patients with atrial fibrillation: a single center survey.
Journal: Journal of thrombosis and thrombolysis
Published: September 24, 2013
Treatment of hemophilia B: focus on recombinant factor IX.
Journal: Biologics : targets & therapy
Published: February 23, 2013
Alloantibodies in previously untreated hemophilia A patients: the role of environmental factors.
Journal: Hematology (Amsterdam, Netherlands)
Published: February 12, 2013
Non-O blood group as a risk factor for cerebral vein thrombosis.
Journal: Thrombosis and haemostasis
Published: February 09, 2013
Pure white cell aplasia induced by mesalazine in a patient with ulcerative colitis.
Journal: Hematology (Amsterdam, Netherlands)
Published: January 17, 2013
Last Updated: 09/26/2026